| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
22,195 |
21,600 |
$6.08M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
25,242 |
24,676 |
$4.78M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
10,100 |
9,754 |
$3.70M |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
17,627 |
17,366 |
$2.11M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,822 |
7,437 |
$1.09M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,405 |
2,357 |
$647K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
5,960 |
5,742 |
$522K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,142 |
4,058 |
$463K |
| 71046 |
Radiologic examination, chest; 2 views |
7,855 |
7,698 |
$421K |
| 71045 |
Radiologic examination, chest; single view |
7,419 |
7,135 |
$364K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,892 |
1,602 |
$347K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
5,171 |
4,649 |
$314K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
8,862 |
8,606 |
$278K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,868 |
5,164 |
$261K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
7,476 |
2,399 |
$247K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,716 |
5,319 |
$243K |
| 59025 |
Fetal non-stress test |
1,844 |
1,027 |
$239K |
| 80053 |
Comprehensive metabolic panel |
29,176 |
27,320 |
$237K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,268 |
683 |
$235K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
7,253 |
7,097 |
$228K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,014 |
988 |
$223K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,826 |
7,451 |
$165K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
31,212 |
28,201 |
$159K |
| G0378 |
Hospital observation service, per hour |
323 |
304 |
$157K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
286 |
275 |
$155K |
| 36415 |
Collection of venous blood by venipuncture |
43,318 |
38,318 |
$148K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,557 |
1,519 |
$136K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
929 |
901 |
$136K |
| 80061 |
Lipid panel |
10,135 |
9,940 |
$132K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,501 |
1,458 |
$127K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
417 |
413 |
$111K |
| 87480 |
|
4,347 |
4,254 |
$87K |
| 87660 |
|
4,351 |
4,258 |
$86K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
442 |
433 |
$81K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
4,468 |
4,324 |
$75K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,250 |
4,141 |
$75K |
| 93975 |
|
434 |
419 |
$75K |
| 87510 |
|
4,334 |
4,241 |
$71K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
351 |
342 |
$68K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
227 |
225 |
$66K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,438 |
2,402 |
$65K |
| T1015 |
Clinic visit/encounter, all-inclusive |
1,073 |
370 |
$62K |
| 76830 |
Ultrasound, transvaginal |
732 |
715 |
$58K |
| 84702 |
|
5,626 |
5,318 |
$57K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
533 |
494 |
$57K |
| 82728 |
|
4,080 |
3,969 |
$51K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
6,242 |
6,089 |
$51K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,951 |
3,779 |
$47K |
| 97161 |
|
790 |
781 |
$45K |
| 80050 |
General health panel |
2,256 |
2,200 |
$43K |
| 86803 |
|
2,646 |
2,597 |
$41K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
728 |
397 |
$40K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,944 |
1,502 |
$40K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
813 |
766 |
$39K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
853 |
831 |
$38K |
| 87490 |
|
1,581 |
1,486 |
$38K |
| 87631 |
|
250 |
240 |
$38K |
| 84484 |
|
3,421 |
3,081 |
$37K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
72 |
71 |
$34K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
486 |
474 |
$34K |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
1,974 |
1,960 |
$34K |
| 73564 |
|
678 |
608 |
$32K |
| 96367 |
|
787 |
426 |
$32K |
| 84466 |
|
2,392 |
2,303 |
$30K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,093 |
3,460 |
$30K |
| 86696 |
|
1,562 |
1,414 |
$30K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
199 |
195 |
$28K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
958 |
925 |
$27K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
93 |
90 |
$26K |
| 73610 |
|
601 |
560 |
$26K |
| 76642 |
|
453 |
423 |
$26K |
| 83735 |
|
5,507 |
4,695 |
$26K |
| 86900 |
|
543 |
512 |
$25K |
| 73630 |
|
662 |
614 |
$25K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
605 |
480 |
$25K |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
1,640 |
1,608 |
$24K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
117 |
117 |
$24K |
| 93971 |
|
289 |
274 |
$23K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
762 |
375 |
$23K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,110 |
430 |
$23K |
| 72141 |
|
86 |
85 |
$23K |
| 77066 |
Tomosynthesis, mammo |
241 |
231 |
$23K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
433 |
359 |
$23K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
310 |
302 |
$23K |
| 72110 |
|
480 |
474 |
$22K |
| 77065 |
Tomosynthesis, mammo |
361 |
348 |
$22K |
| 86480 |
|
299 |
292 |
$22K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
270 |
262 |
$21K |
| 83655 |
|
1,709 |
1,696 |
$21K |
| 73030 |
|
571 |
530 |
$21K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,598 |
2,457 |
$21K |
| 87340 |
|
1,918 |
1,887 |
$20K |
| 93970 |
|
148 |
146 |
$19K |
| 93017 |
|
241 |
231 |
$19K |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
776 |
768 |
$19K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
54 |
52 |
$19K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
219 |
213 |
$19K |
| 83690 |
|
4,649 |
4,469 |
$19K |
| 82607 |
|
1,606 |
1,572 |
$19K |
| 76770 |
|
276 |
264 |
$18K |
| 76801 |
|
232 |
221 |
$17K |
| 87081 |
|
2,376 |
2,332 |
$17K |
| 97162 |
|
275 |
272 |
$17K |
| 83540 |
|
2,513 |
2,421 |
$16K |
| 81001 |
|
7,031 |
6,768 |
$15K |
| 73130 |
|
435 |
363 |
$15K |
| 85027 |
|
2,284 |
2,140 |
$15K |
| 86618 |
|
324 |
317 |
$15K |
| 82150 |
|
3,873 |
3,736 |
$15K |
| 72050 |
|
283 |
274 |
$15K |
| 83525 |
|
1,180 |
1,148 |
$14K |
| 76536 |
|
191 |
190 |
$14K |
| 73110 |
|
402 |
343 |
$14K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
465 |
462 |
$14K |
| 87150 |
|
302 |
291 |
$14K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
304 |
289 |
$13K |
| 73562 |
|
334 |
299 |
$13K |
| 97802 |
|
235 |
223 |
$13K |
| 82784 |
|
513 |
501 |
$13K |
| 80081 |
|
133 |
130 |
$12K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
164 |
103 |
$12K |
| 93225 |
|
245 |
236 |
$12K |
| 86003 |
|
148 |
131 |
$12K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
496 |
479 |
$12K |
| 84439 |
|
1,181 |
1,144 |
$11K |
| 86592 |
|
2,710 |
2,654 |
$11K |
| 85610 |
|
2,993 |
1,743 |
$11K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
464 |
445 |
$11K |
| 72100 |
|
209 |
205 |
$10K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
210 |
195 |
$10K |
| 80074 |
|
142 |
138 |
$10K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
126 |
113 |
$10K |
| 82746 |
|
883 |
864 |
$9K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
366 |
169 |
$9K |
| 62323 |
|
15 |
14 |
$9K |
| 73502 |
|
220 |
213 |
$9K |
| 74018 |
|
210 |
193 |
$8K |
| 83970 |
|
210 |
200 |
$8K |
| 71250 |
|
112 |
108 |
$8K |
| 86038 |
|
497 |
491 |
$7K |
| 84403 |
|
262 |
240 |
$7K |
| 82570 |
|
1,051 |
986 |
$7K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,139 |
2,954 |
$7K |
| 80076 |
|
722 |
671 |
$6K |
| 84146 |
|
285 |
273 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
135 |
115 |
$6K |
| 97803 |
|
231 |
228 |
$6K |
| 84480 |
|
478 |
467 |
$6K |
| 73221 |
|
26 |
26 |
$6K |
| 87186 |
|
662 |
635 |
$6K |
| 64483 |
|
18 |
13 |
$6K |
| 36430 |
|
24 |
13 |
$5K |
| 81003 |
|
2,349 |
2,284 |
$5K |
| 73140 |
|
136 |
129 |
$5K |
| 96417 |
|
68 |
36 |
$5K |
| 93880 |
|
62 |
61 |
$5K |
| 83001 |
|
257 |
245 |
$5K |
| 82043 |
|
652 |
621 |
$5K |
| 73080 |
|
140 |
124 |
$5K |
| 86850 |
|
324 |
306 |
$5K |
| G0433 |
Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening |
292 |
266 |
$5K |
| 97165 |
|
92 |
89 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
239 |
170 |
$4K |
| 95819 |
|
29 |
27 |
$4K |
| 77085 |
|
71 |
70 |
$4K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
53 |
49 |
$4K |
| 85018 |
|
1,338 |
1,315 |
$4K |
| 85652 |
|
1,294 |
1,240 |
$4K |
| 85014 |
|
1,332 |
1,310 |
$4K |
| 83721 |
|
357 |
343 |
$4K |
| 82077 |
|
133 |
124 |
$4K |
| 86140 |
|
804 |
768 |
$3K |
| 87077 |
|
409 |
398 |
$3K |
| 76641 |
|
44 |
38 |
$3K |
| 83002 |
|
163 |
155 |
$3K |
| 83718 |
|
416 |
415 |
$3K |
| 87040 |
|
241 |
216 |
$3K |
| 86706 |
|
250 |
247 |
$3K |
| 85730 |
|
566 |
531 |
$3K |
| 86430 |
|
372 |
366 |
$3K |
| 82330 |
|
266 |
245 |
$3K |
| 86704 |
|
200 |
197 |
$3K |
| 86901 |
|
320 |
302 |
$3K |
| 82248 |
|
425 |
398 |
$3K |
| 82397 |
|
673 |
610 |
$3K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
467 |
454 |
$3K |
| 80320 |
|
83 |
74 |
$2K |
| 82950 |
|
385 |
374 |
$2K |
| 86762 |
|
142 |
142 |
$2K |
| 82565 |
|
486 |
455 |
$2K |
| 85007 |
|
593 |
576 |
$2K |
| 84100 |
|
423 |
371 |
$2K |
| 83615 |
|
364 |
348 |
$2K |
| 87147 |
|
333 |
311 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
69 |
68 |
$2K |
| 87070 |
|
277 |
266 |
$2K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
215 |
209 |
$2K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
87 |
86 |
$2K |
| 82947 |
|
468 |
459 |
$2K |
| 84436 |
|
288 |
281 |
$2K |
| 86787 |
|
133 |
133 |
$2K |
| 82550 |
|
282 |
273 |
$2K |
| 82465 |
|
439 |
438 |
$2K |
| 80051 |
|
336 |
320 |
$2K |
| 84153 |
|
76 |
76 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
153 |
152 |
$2K |
| 82785 |
|
102 |
101 |
$2K |
| 83605 |
|
278 |
251 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,483 |
3,012 |
$2K |
| 84450 |
|
261 |
253 |
$2K |
| 73590 |
|
47 |
42 |
$2K |
| 84156 |
|
370 |
338 |
$2K |
| 84402 |
|
54 |
52 |
$2K |
| 71271 |
|
28 |
28 |
$1K |
| 84460 |
|
235 |
223 |
$1K |
| 81025 |
|
276 |
270 |
$1K |
| 84520 |
|
361 |
344 |
$1K |
| 83516 |
|
121 |
107 |
$1K |
| 82670 |
|
50 |
50 |
$1K |
| 82962 |
|
1,031 |
780 |
$1K |
| 85379 |
|
132 |
129 |
$1K |
| 84550 |
|
216 |
205 |
$1K |
| 87088 |
|
145 |
140 |
$1K |
| 96376 |
|
205 |
138 |
$1K |
| 87522 |
Neg quan hep c or qual rna |
28 |
27 |
$1K |
| 84481 |
|
54 |
54 |
$1K |
| 94060 |
|
12 |
12 |
$1K |
| 72072 |
|
16 |
16 |
$935.85 |
| 84165 |
|
71 |
71 |
$930.57 |
| 87205 |
|
204 |
196 |
$898.10 |
| 85378 |
|
105 |
99 |
$824.76 |
| 72082 |
|
12 |
12 |
$798.22 |
| 72070 |
|
14 |
14 |
$797.00 |
| 85046 |
|
119 |
112 |
$786.71 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
42 |
33 |
$752.75 |
| 82951 |
|
50 |
48 |
$747.54 |
| 97022 |
|
80 |
24 |
$732.42 |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
113 |
113 |
$726.37 |
| 86200 |
|
39 |
39 |
$651.54 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,008 |
809 |
$650.55 |
| 83020 |
|
42 |
42 |
$604.03 |
| 87427 |
|
26 |
25 |
$602.77 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,844 |
1,401 |
$599.78 |
| 94760 |
|
241 |
208 |
$576.75 |
| 86235 |
|
17 |
12 |
$559.62 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,232 |
2,903 |
$540.63 |
| 90715 |
|
16 |
15 |
$420.85 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,731 |
2,919 |
$396.98 |
| 86703 |
|
15 |
15 |
$381.75 |
| 83883 |
|
39 |
39 |
$350.84 |
| J2704 |
Injection, propofol, 10 mg |
1,557 |
1,319 |
$342.91 |
| 88304 |
|
29 |
28 |
$318.44 |
| 82627 |
|
13 |
13 |
$305.55 |
| 86617 |
|
12 |
12 |
$277.12 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
581 |
407 |
$272.83 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,526 |
1,259 |
$272.45 |
| 87045 |
|
25 |
25 |
$244.77 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
110 |
70 |
$218.38 |
| 86160 |
|
14 |
13 |
$216.30 |
| 87341 |
|
24 |
24 |
$212.86 |
| 87046 |
|
25 |
25 |
$208.31 |
| 85660 |
|
40 |
40 |
$197.40 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
814 |
531 |
$131.72 |
| 82952 |
|
29 |
28 |
$121.56 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
613 |
447 |
$118.57 |
| 87328 |
|
12 |
12 |
$113.24 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,304 |
1,125 |
$77.82 |
| J1644 |
Injection, heparin sodium, per 1000 units |
89 |
41 |
$43.93 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
933 |
425 |
$41.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
183 |
167 |
$32.80 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
58 |
52 |
$23.72 |
| J2060 |
Injection, lorazepam, 2 mg |
74 |
51 |
$20.23 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,153 |
974 |
$12.22 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
69 |
66 |
$12.13 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
41 |
39 |
$11.48 |
| 3044F |
|
339 |
329 |
$0.03 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
180 |
166 |
$0.00 |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
327 |
120 |
$0.00 |
| J1756 |
Injection, iron sucrose, 1 mg |
154 |
66 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
31 |
24 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
12 |
12 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
68 |
60 |
$0.00 |
| 3061F |
|
66 |
62 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
58 |
36 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
103 |
62 |
$0.00 |
| J3490 |
Unclassified drugs |
32 |
26 |
$0.00 |